Summary
This study investigates the neuroprotective effects of chronic melatonin treatment on cognitive deficits in the Ts65Dn mouse model of Down syndrome, which shares multiple phenotypic characteristics with the human condition. Findings may inform therapeutic use of melatonin supplementation for neurodevelopmental and neurodegenerative conditions involving cognitive decline.
Categories
Sleep & Circadian Health: Melatonin treatment is examined for its effects on cognitive deficits, with melatonin's role as a circadian hormone being central to the intervention.
Dementia & Elder Care: Down syndrome involves progressive neurodegeneration and early-onset Alzheimer's-like pathology, making findings relevant to neurodegenerative care contexts.
Author(s)
A Corrales Pardo
Publication Year
2015
Related Publications
Sleep & Circadian Health
- Phototransduction by retinal ganglion cells that set the circadian clock
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks
- The two‐process model of sleep regulation: a reappraisal
- Melanopsin is required for non-image-forming photic responses in blind mice
- Strange vision: ganglion cells as circadian photoreceptors
Dementia & Elder Care
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The clock is ticking. Ageing of the circadian system: from physiology to cell cycle